Orphan Drugs: Hope Where There Is Little or No Hope

NEW YORK, N.Y., February 18, 2004 ? On a visit to his doctor, Gary Jacob received distressing news ? not about himself, but a friend of the doctor's.

While playing with one of his children, the doctor's friend fell and broke a rib. That was bad enough, but during the examination at the hospital, the father was hit with a startling and totally unexpected diagnosis ? he had a disease known as multiple myeloma, a bone marrow blood cancer.

The diagnosis was nothing less than a death sentence.

Jacob knew of the anguish of multiple myeloma patients. The disease is incurable and nearly always fatal, one of the rare diseases that have few, if any, available treatments. They are known as "orphan" diseases, shunned by most drug-makers because the patient populations are small and commercial development of a drug is seen as economically unattractive.

Mr. Jacob was aware because, as Chief Executive Officer of Callisto Pharmaceuticals, Inc., a small Manhattan-based biopharmaceutical company, he is leading a scientific effort to develop a new orphan drug called "Atiprimod" for multiple myeloma patients.

"The father's disease brought home to me that what we are doing is really important," says Mr. Jacob. "Everyone agrees we need more drugs to treat multiple myeloma. There are people out there dying without real hope because of a lack of effective treatment for all patients."

In steadily increasing numbers, orphan drugs are providing new doses of hope where little or none at all existed. In the decade before the inception of the federal Food and Drug Administration's orphan drug program, 10 drugs were developed by pharmaceutical companies for orphan diseases. In the decades since, the FDA says nearly 250 new drugs were developed and approved, and hundreds more are in the pipeline.

Atiprimod is one of those wending its way toward the marketplace. Callisto recently obtained orphan drug designation from the FDA, providing the company with financial incentives to continue the costly development process.

The program covers drugs for orphan diseases with patient populations under 200,000.

The National Organization for Rare Disorders reports about 25 million people in the United States suffer from an estimated 6,000 orphan diseases.

Diseases such as cystic fibrosis, complications affecting HIV-infected people, Gaucher's disease, hemophilia and rare forms of cancer were among the orphans without effective medicines until the FDA program went into effect in 1983 and paved the way for new drugs for patients with these diseases.

Large drug-makers have been largely missing from the efforts.

According to the orphan drug program's deputy director, Dr. John McCormick, only 15% of applications for orphan drug designation have come from the larger pharmaceutical companies.

The reason: expectations of unfavorable investment returns.

The FDA orphan drug incentives ? grants, seven years of marketing exclusivity and tax breaks ? have drawn small pharmaceutical companies with promising drug candidates into the breach.

While the future is brighter, the task is still daunting to develop drugs for orphan diseases.

Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects 30,000 Americans with 8,000 new cases diagnosed annually; Huntington's disease also affects about 30,000 patients.

Some diseases affect fewer than 100 patients, according to the National Institutes of Health.

An estimated 50,000 patients have multiple myeloma with 15,000 new patients diagnosed each year. Last year, the FDA approved a new drug Velcade for patients with the disease. However, there are still a number of multiple myeloma patients with no treatment available.

Dr. Kenneth C. Anderson, who played a major role in the preclinical development and clinical trials of Velcade and is now a member of Callisto's Medical Advisory Board, is among the experts who see a need for more drugs to treat multiple myeloma.

"He is excited to see Atiprimod enter clinical trials for evaluation in multiple myeloma patients," Jacob said of Anderson. "He believes it has an opportunity to help patients who have not responded to other drugs. "

Dr. Anderson is director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute in Boston, MA, and Professor of Medicine at Harvard Medical School.

The Phase I/IIa trials for Atiprimod are slated to begin later this month.

Dr. Donald Picker, Callisto's Senior Vice President of Drug Development, said studies of Atiprimod in collaboration with scientists at the National Cancer Institute have been very promising.

"In essence, we've shown in these early studies that Atiprimod has the potential to intervene with cancer cells and tumors in three ways ? by inhibiting their formation, by programming their death and by limiting their ability to grow blood vessels necessary for their survival. Taken together, these findings suggest that Atiprimod could potentially represent a novel class of compounds for development for therapeutic intervention in human cancers," said Dr. Picker.

About The Author

Alex Michelini is a former award-winning reporter/editor at the New York Daily News. His credits include nomination for a Pulitzer Prize for a series on medical costs. Among his honors, Mr. Michelini received the Deadline Club Award, the Page One Award, the Associated Press Award and the New York Press Club Award (twice). He is the founder of Alex Michelini Public Relations, and has developed and collaborated on articles appearing in the New York Times, the Wall Street Journal, the London Times, the New York Post, the New York Daily News, Bloomberg Radio & TV, CNNfn, WCBS Radio & TV. WINS radio, the Christian Science Monitor, Fox TV, Reuters, Newsday and other media outlets.

michelinialex@aol.com

---

Interactive Technology in Healthcare Education

Healthcare professionals are under pressure to remember, utilize and absorb... Read More

The Check Doctor Credentials Theory

In 2003, there where more than 890 million doctor visits... Read More

The Trouble with Tranqs

There's a whole group of drugs out there called benzodiazepines.They... Read More

Web Therapy: Enhancing Patient Communication with Web Access

According to Jennifer Lyons' chart, she's just a bad slip... Read More

Medical Malpractice Suits: Death By Medicine

A recent report has found that Americans are more frightened... Read More

Thimerosal: Autism and Mercury Poisoning Side Effects?

Thimerosal is a preservative that is added to vaccines (has... Read More

?Foot Pain Relief At Last!?

"As an arthritis specialist, one area that I see people... Read More

What Not to Tell Your Doctor?

For many years since medicine has been established as an... Read More

Zyprexa Lawsuits

Zyprexa is an antipsychotic medication that works by changing the... Read More

Cut Your Prescription Drug Costs Without Having to Buy Foreign Drugs

Save Up to 93% by Asking for a Generic -... Read More

Drug Them and Send Them Out

It was around 1986, when my son Lewis was diagnosed... Read More

Latest Medical Spa Equipment Showcased at New York Medical Spa Expo

This year, the New York Medical Spa Expo confirmed the... Read More

Technology Over Drugs for Stress Related Tension Disorders

As much as 95% of the population suffers from some... Read More

How You Can Erase Low Back Pain Using the Latest Medical Techniques!

"If you're one the nine out of ten adults in... Read More

Propulsid Litigation Lawyer Says: Unnecessary Drug Killed 80 People

Propulsid was a popular nighttime heartburn drug before it was... Read More

Common Drugs and Their Uses

The five drugs that are discussed in this article are... Read More

Stop Taking Blood Pressure Medications with Your Doctors Approval

I have been swallowing three varieties of blood pressure pills... Read More

Ingrown Toe Nails Medical Treatment

Medical Care:Treatment options depend on the stage of ingrown toenails,... Read More

?Get Rid of Tendonitis ? Now!? Advice From An Expert?

Tendons are ropes of fibrous tissue that connect muscles to... Read More

High Cholesterol Prescription Medications Can Kill You

The World Health Organization declares that heart disease is the... Read More

Mexico: Drugs Galore!

You are going to find this incredible and I assure... Read More

Hemorrhoids Treatment - A Variety of Options

A variety of options exist for hemorrhoid treatment including surgery,... Read More

First Responder Human Hibernation Units

In the next few years paramedics, first responders and military... Read More

Lamisil Side Effects Lawyer: Lamisil Tablet

While the recent Lamisil commercial featuring Digger, a disgusting cartoon... Read More

4 Reasons Why You Should Use Canadian Pharmacies

Let's face it: purchasing prescription drugs in the U.S. can... Read More

Blood Pressure Treatment: High and Low Blood Pressure Tips and Medication!

High blood pressure is on the rise worldwide. But, doctors... Read More

Nasonex And You: Breathe Easy, Not Sneezy

While everybody else is wandering around enjoying the spring weather,... Read More

An Introduction to Acid Reflux Disease

Acid reflux disease, also known as Gastroesophageal Reflux Disease or... Read More

Prescription Drug Benefit Cost Understated by $324 Billion!

When the legislation was passed for Bush's prescription drug benefit... Read More

Coumadin Users Can Avoid Unnecessary Complications By Wearing Identification

The police arrive at the accident scene promptly. A driver... Read More

Building A Medical Spa Inside Your Existing Medical Practice

The physicians conundrum: Everywhere, physicians are contemplating or engaged in... Read More

Study Confirms IBS Improvement

Irritable bowel syndrome is a debilitating and distressing condition, which... Read More

After Viagra, Its Now a Premature Orgasm Pill for Women

Pfizer's exciting drug history traces back to the most popular... Read More